SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →VRTX
Vertex Pharmaceuticals is a biotechnology company focused on developing and commercializing therapies for serious diseases, especially cystic fibrosis.
- Open
- 524.71
- High
- 531.37
- Low
- 513.80
- Prev close
- 520.66
- Volume
- 2M
- Avg vol 10
- 1M
Today · Market closed · opens Mon 9:30 AM
VRTX chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 518.00
No clear lean. 4 buy, 9 neutral and 5 sell across 18 signals. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 12).
Trend
Momentum
Volatility
Volume
Leaning sell. The close is above 8 of 24 averages and below 16. Price is below the short-term averages (5 to 20) and above the long-term ones (50 to 200). SMA 50 is above SMA 200 (522.79 vs 484.89).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 529.42 | 527.54 | 525.88 | 532.19 |
| 10 | 537.41 | 532.78 | 532.27 | 533.42 |
| 20 | 538.19 | 533.24 | 537.61 | 528.95 |
| 50 | 522.79 | 526.28 | 528.38 | 513.58 |
| 100 | 516.72 | 513.31 | 523.86 | 492.42 |
| 200 | 484.89 | 491.13 | 501.56 | 470.44 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is S1 at 513.06. Nearest resistance is the pivot at 525.42.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 565.36 | 545.39 | 526.15 | 553.00 | 559.90 | — |
| R2 | 545.39 | 537.76 | 524.32 | 545.39 | 548.84 | — |
| R1 | 533.03 | 533.05 | 522.49 | 533.03 | 539.93 | 529.23 |
| Pivot | 525.42 | 525.42 | 525.42 | 525.42 | 528.87 | 523.52 |
| S1 | 513.06 | 517.79 | 518.83 | 513.06 | 519.96 | 509.26 |
| S2 | 505.45 | 513.08 | 517.00 | 505.45 | 508.90 | — |
| S3 | 485.48 | 505.45 | 515.17 | 493.09 | 499.99 | — |
Patterns that formed on the last 5 bars, newest first.
An engulfing pattern (a candle swallowing the one before) followed by a third candle that closes further the same way.
A confirmed engulfing: a turn down from an advance.
A candle with a long body and short shadows.
Sellers controlled the bar.
A long down candle, then an up candle that opens lower and closes at the first candle's low.
The decline is expected to carry on.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A candle with a long body and short shadows.
Sellers controlled the bar.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 529.94 | 531.37 | 513.80 | 518.00 | 2M | −11.94 |
| Nov 19, 2026 | 537.79 | 537.79 | 517.82 | 520.66 | 1M | −17.13 |
| Nov 18, 2026 | 532.27 | 542.76 | 531.38 | 536.45 | 1M | +4.18 |
| Nov 17, 2026 | 532.76 | 538.56 | 529.00 | 534.20 | 2M | +1.44 |
| Nov 16, 2026 | 547.86 | 549.56 | 534.12 | 537.79 | 1M | −10.07 |
| Nov 13, 2026 | 542.12 | 543.73 | 536.12 | 538.60 | 758K | −3.52 |
| Nov 12, 2026 | 547.87 | 552.27 | 542.51 | 542.62 | 987K | −5.25 |
| Nov 11, 2026 | 543.96 | 548.67 | 535.46 | 547.03 | 1M | +3.07 |
| Nov 10, 2026 | 546.97 | 551.86 | 543.44 | 547.89 | 1M | +0.92 |
| Nov 9, 2026 | 555.99 | 555.99 | 538.48 | 550.87 | 1M | −5.12 |
| Nov 6, 2026 | 531.53 | 548.76 | 531.53 | 547.09 | 1M | +15.56 |
| Nov 5, 2026 | 556.85 | 557.85 | 540.02 | 542.50 | 2M | −14.35 |
| Nov 4, 2026 | 535.63 | 550.77 | 527.38 | 549.04 | 2M | +13.41 |
| Nov 3, 2026 | 558.44 | 561.96 | 529.15 | 530.76 | 2M | −27.68 |
| Nov 2, 2026 | 560.88 | 568.67 | 544.09 | 553.15 | 3M | −7.73 |
| Oct 30, 2026 | 550.73 | 563.80 | 549.89 | 558.88 | 3M | +8.15 |
| Oct 29, 2026 | 536.46 | 546.61 | 534.01 | 540.00 | 2M | +3.54 |
| Oct 28, 2026 | 514.45 | 534.94 | 513.37 | 529.69 | 1M | +15.24 |
| Oct 27, 2026 | 514.84 | 521.43 | 509.21 | 521.03 | 1M | +6.19 |
| Oct 26, 2026 | 526.86 | 529.66 | 509.33 | 517.49 | 1M | −9.37 |
| Oct 23, 2026 | 531.66 | 533.08 | 522.91 | 523.93 | 833K | −7.73 |
| Oct 22, 2026 | 527.18 | 537.81 | 521.30 | 535.17 | 2M | +7.99 |
| Oct 21, 2026 | 512.79 | 528.57 | 510.48 | 524.52 | 1M | +11.73 |
| Oct 20, 2026 | 507.89 | 515.74 | 505.00 | 514.65 | 1M | +6.76 |
| Oct 19, 2026 | 500.00 | 505.83 | 499.50 | 501.95 | 1M | +1.95 |
| Oct 16, 2026 | 511.06 | 512.21 | 497.49 | 499.74 | 1M | −11.32 |
| Oct 15, 2026 | 514.91 | 517.68 | 507.21 | 508.75 | 2M | −6.16 |
| Oct 14, 2026 | 490.45 | 502.94 | 487.54 | 498.50 | 2M | +8.05 |
| Oct 13, 2026 | 507.55 | 508.57 | 484.08 | 485.22 | 1M | −22.33 |
| Oct 12, 2026 | 512.44 | 514.80 | 506.00 | 507.00 | 954K | −5.44 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
-3.77%
Change in value over the past month.
3 month return
-5.95%
Change in value over the last three months.
Max drawdown
15.21%
Largest fall from a peak to the low that followed.
Standard deviation
29.80%
How far daily returns stray from their average, annualised.
Sharpe ratio
0.64
Return above the risk-free rate per unit of volatility.
Calmar ratio
1.25
Annualised return against the maximum drawdown.
VRTX summary
Loading summary…
VRTX, answered
When was Vertex founded?
Vertex was founded in 1989 and is headquartered in Boston, Massachusetts.
Is VRTX publicly traded?
Yes, Vertex is publicly traded on the NASDAQ under the ticker symbol VRTX.
What is Vertex’s commitment to innovation?
Vertex is committed to innovation, investing significantly in research to develop groundbreaking therapies for unmet medical needs.
What diseases does Vertex focus on?
Vertex primarily focuses on cystic fibrosis, but also explores therapies for other serious genetic diseases and pain.
How does Vertex support patient access to its medications?
Vertex has programs to help patients access their medications, including financial assistance and patient education resources.
How does Vertex engage with the community?
Vertex engages with the community through initiatives aimed at supporting patients, advocacy, and scientific research.
What is Vertex’s approach to clinical trials?
Vertex conducts rigorous clinical trials to ensure the safety and efficacy of its therapies before they reach the market.
How can investors find more information about Vertex?
Investors can find financial reports, news, and updates on Vertex’s official investor relations website.
What challenges does Vertex face?
Vertex faces challenges such as competition from other biotech companies, regulatory hurdles, and the high cost of drug development.
What is the financial outlook for Vertex?
Vertex has a strong financial outlook due to its successful products and ongoing R&D efforts, though market competition remains a consideration.
VRTX in the news
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Empower Your VRTX Trading Now
Take control of your trading with OHLCX. Our platform offers unparalleled analysis and technical support for VRTX, designed to enhance your market performance. Transform your trading strategy now and experience the difference with our expert tools!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.